Cornerstone Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-44,000
Closed -$3.49M 241
2018
Q2
$3.49M Hold
44,000
0.42% 66
2018
Q1
$3.92M Hold
44,000
0.47% 66
2017
Q4
$4.59M Hold
44,000
0.52% 52
2017
Q3
$6.42M Buy
+44,000
New +$5.99M 0.74% 38
2017
Q1
Sell
-23,000
Closed -$2.66M 277
2016
Q4
$2.66M Buy
23,000
+16,000
+229% +$1.78M 0.49% 63
2016
Q3
$732K Hold
7,000
0.19% 126
2016
Q2
$690K Sell
7,000
-10,000
-59% -$1.03M 0.17% 132
2016
Q1
$1.7M Hold
17,000
0.41% 71
2015
Q4
$2.04M Hold
17,000
0.47% 63
2015
Q3
$1.84M Buy
17,000
+7,000
+70% +$869K 0.43% 62
2015
Q2
$1.16M Buy
+10,000
New +$1.14M 0.26% 106
2013
Q3
Sell
-19,000
Closed -$1.11M 252
2013
Q2
$1.11M Buy
+19,000
New +$1.14M 0.44% 72

Other funds holding CELG

Cornerstone Advisors's CELG Position: Q3 2018 in Review

Cornerstone Advisors sold out of Celgene Corp (CELG) in Q3 2018, closing a stake of 44,000 shares — an estimated $3.49M sold.

Cornerstone Advisors first reported a position in CELG in Q2 2013 and held it in 12 quarters. The position peaked at $6.42M in Q3 2017. 1,364 funds tracked by Wall St. Rank hold CELG as of Q3 2018.

  • Cornerstone Advisors reported no remaining Celgene Corp position as of Q3 2018 after selling out during the quarter.
  • Cornerstone Advisors sold 44,000 Celgene Corp shares in Q3 2018, an estimated $3.49M.
  • Cornerstone Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 12 quarters.
  • Cornerstone Advisors's Celgene Corp position peaked at $6.42M in Q3 2017.
  • 1,364 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2018.

Based on Cornerstone Advisors's 13F filing for Q3 2018, filed 13 Nov 2018.